相关实验视频
Updated: Jul 31, 2026

07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
34.6K
无法逆转的电穿孔:超出了瘤剥离的极限
R Alonso-González1, J M Abadal Villayandre1, E Gálvez Gonzalez1
1Radiología Vascular Intervencionista, Hospital Universitario Severo Ochoa, Madrid, Spain.
Radiologia
|February 16, 2024
概括
不可逆的电穿孔 (IRE) 使用电脉冲进行非热性瘤切除,为附近的重要结构提供安全的替代方案. 这种有前途的技术显示出治疗各种癌症的潜力,甚至可能影响远程转移.
科学领域:
- 在瘤学瘤学.
- 医疗器械 医疗器械
- 生物物理学的生物物理.
背景情况:
- 不可逆的电穿孔 (IRE) 是一种新兴的用于瘤治疗的非热剥离技术.
- 它利用高压电脉冲诱导细胞膜纳米孔和细胞亡.
- IRE在接近敏感血管系统时是有利的,因为热方法是禁忌的.
研究的目的:
- 审查癌症治疗中不可逆转电穿孔 (IRE) 的原则,应用和潜力.
- 突出其在治疗胰腺,脏,肝脏和前列腺癌等特定瘤方面的有效性.
- 讨论挑战和未来前景,包括其免疫学影响.
主要方法:
- 通过在瘤周围或瘤内部插入的电极,应用高压电脉冲.
- 在细胞膜中诱导纳米孔,导致细胞被编程死亡 (细胞亡).
- 在治疗胰腺,脏,肝脏和前列腺癌的临床应用.
主要成果:
- IRE在各种器官中证明了成功的瘤切除.
- 该技术可以在微妙的血管结构附近安全地应用.
- IRE表现出诱导全身免疫反应的潜力,包括abscopal效应.
结论:
- 不可逆的电穿孔 (IRE) 是一种适用于特定癌症的可行的非热剥离方法.
- 虽然IRE复杂,需要专家团队,但它比热除具有独特的优势.
- 它对全身免疫疗法和腹腔效应的潜力需要进一步研究.
关键词:
废弃的技术 废弃的技术电解成形是一种电解成形.电解是不可逆转的.电穿孔是一种电子穿孔.免疫治疗是一种免疫疗法.免疫疗法是一种免疫疗法.干预性 干预性 干预性无法逆转的电穿孔疗法.肝脏的新生体是什么医学瘤学 医学瘤学肝脏新形成症 (neoplasias hepáticas) 是一种肝脏新形成症.胰腺新形成症 (Neoplasias pancreáticas) 是一种胰腺新形成症.这种新发性脏病 (Neoplasias renales) 是一种新发性脏病.瘤学 在瘤学方面胰腺新生体的发生.放射学 放射学是一门学科.辐射学 辐射学干预性放射学 (Radiología intervencionista) 是一种干预性的放射学.脏瘤是什么 脏瘤是什么除技术的使用.相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

